Literature DB >> 17049120

Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.

Chun-yan Sun1, Yu Hu, Tao Guo, Hua-fang Wang, Xiao-ping Zhang, Wen-juan He, Hao Tan.   

Abstract

AIM: To examine the in vitro antitumor activity of resveratrol against multiple myeloma (MM) cell lines (RPMI 8226, U266, and KM3), and the mechanisms involved.
METHODS: The growth inhibition of resveratrol was determined by 3-(4, 5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The effect of resveratrol on the apoptosis was investigated by combined annexin V-propidium iodide staining. The effect of resveratrol on the invasion through Matrigel matrix was detected by transwell invasion analyses. The activity of matrix metalloproteinase (MMP)-2 and -9 proteins were determined by gelatin zymography analysis. The expression of MMP-2, MMP-9, Bcl-2, Bcl-x(L), XIAP and Bax protein were detected using Western blotting analysis.
RESULTS: Resveratrol inhibited proliferation of MM cells in a dose- and time-dependent manner. Incubation of MM cells with resveratrol resulted in apoptotic cell death. Resveratrol down-regulated the expression of the antiapoptotic proteins Bcl-2, Bcl-x(L) and XIAP and up-regulated the expression of the proapoptotic protein Bax. Furthermore, resveratrol inhibited invasion of RPMI 8226, U266, and KM3 cells with IC50 values of 64+/-8 micromol/L, 93+/-11 micromol/L, and 153+/-11 micromol/L, respectively. Resveratrol inhibited the constitutive expression of MMP-2 and -9 proteins of MM cells and suppressed its gelatinolytic activity.
CONCLUSION: Resveratrol inhibits the proliferation of MM cells by inducing apoptotic cell death. Resveratrol also inhibits MM cell invasion. The inhibition of invasion may be associated with the attenuation of the enzymatic activities of MMP-2 and -9.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049120     DOI: 10.1111/j.1745-7254.2006.00343.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  21 in total

1.  Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.

Authors:  Zhou Shan; Guo Yang; Wang Xiang; Wang Pei-jun; Zhang Bin
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-03       Impact factor: 4.553

2.  Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling.

Authors:  Lei Zhen; De-sheng Fan; Yan Zhang; Xin-ming Cao; Li-ming Wang
Journal:  Acta Pharmacol Sin       Date:  2014-12-22       Impact factor: 6.150

Review 3.  Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.

Authors:  Saleh A Almatroodi; Mohammed A Alsahli; Abdullah S M Aljohani; Fahad A Alhumaydhi; Ali Yousif Babiker; Amjad Ali Khan; Arshad Husain Rahmani
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

4.  Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds.

Authors:  Andrea De Pieri; Keegan Ocorr; Kyle Jerreld; Mikkael Lamoca; Wolfgang Hitzl; Karin Wuertz-Kozak
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

Review 5.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

Authors:  Mohammad Athar; Jung Ho Back; Levy Kopelovich; David R Bickers; Arianna L Kim
Journal:  Arch Biochem Biophys       Date:  2009-06-15       Impact factor: 4.013

6.  Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.

Authors:  Katarzyna Kupisiewicz; Patrice Boissy; Basem M Abdallah; Frederik Dagnaes Hansen; Reinhold G Erben; Jean-Francois Savouret; Kent Søe; Thomas L Andersen; Torben Plesner; Jean-Marie Delaisse
Journal:  Calcif Tissue Int       Date:  2010-09-15       Impact factor: 4.333

7.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

8.  Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas.

Authors:  Tae-Yon Sung; Sung Ho Choi; Jung Min Lee; Jong Ju Jeong; Sang-Wook Kang; Woong Youn Chung
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

9.  Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.

Authors:  Alina Adriana Ivanescu; Patricia Fernández-Robredo; Henar Heras-Mulero; Luis Manuel Sádaba-Echarri; Laura García-García; Vanessa Fernández-García; Maite Moreno-Orduna; Aitor Redondo-Exposito; Sergio Recalde; Alfredo García-Layana
Journal:  Nutrients       Date:  2015-07-06       Impact factor: 5.717

Review 10.  Resveratrol in prostate diseases - a short review.

Authors:  Milosz Jasiński; Lidia Jasińska; Marcin Ogrodowczyk
Journal:  Cent European J Urol       Date:  2013-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.